Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001

Journal of Infectious Diseases

Volumn 190, Issue 10, 2004, Pages 1739-1744

  Johnson, James R ^a,b,d   Kuskowski, Michael A ^a   Gajewski, Abby ^a,b,e   Sahm, Daniel F ^c   Karlowsky, James A ^c,f  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Focus Technologies Incorporated   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e USA   (United States)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; ESCHERICHIA COLI; MULTIDRUG RESISTANCE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; UNITED STATES;

ADHESINS, ESCHERICHIA COLI; BACTERIAL CAPSULES; BACTERIAL OUTER MEMBRANE PROTEINS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; HEMOLYSIN PROTEINS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; UNITED STATES; VIRULENCE; VIRULENCE FACTORS;

EID: 8444242084     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425018     Document Type: Article

References (35)

1. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: an overlooked epidemic. Microbes Infect 2003; 5:449-56.
2. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli (ExPEC): the "other bad E. coli." J Lab Clin Med 2002; 139:155-62.
3. Johnson JR, Gajewski A, Lesse AJ, Russo TA. Extraintestinal pathogenic Escherichia coli as a cause of invasive non-urinary infections. J Clin Microbiol 2003; 41:5798-802.
4. McBean M, Rajamani S. Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. J Infect Dis 2001; 183:596-603.
5. Diekema DJ, Boots-Miller BJ, Vaughn TE, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004; 38:78-85.
6. Lautenbach E, Strom BL, Nachamkin I, et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 2004; 38:655-62.
7. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002; 46:2540-5.
8. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135:41-50.
9. Garau J, Xercavins M, Rodriguez-Carballeira M, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43:2736-41.
10. MacArthur RD, Miller M, Albertson T, et al. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis 2004; 38:284-8.
11. Vila J, Simon K, Ruiz J, et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 2002; 186:1039-42.
12. Martinez-Martinez L, Fernandez F, Perea EJ. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother 1999; 43:277-9.
13. Johnson JR, Moseley S, Roberts P, Stamm WE. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988; 56:405-12.
14. Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis 2003; 188:759-68.
15. Johnson JR, van der Schee C, Kuskowski MA, Goessens W, van Belkum A. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from The Netherlands. J Infect Dis 2002; 186:1852-6.
16. Karlowsky JA, Kelly LJ, Thornsberry C, et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Int J Antimicrob Agents 2002; 19:21-31.
17. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically [M7-A6]. 6th ed. Vol. 23, no. 2. Wayne, PA: NCCLS, 2003.
18. NCCLS. Performance standards for antimicrobial susceptibility testing: fourteenth informational supplement [M100-S14]. Vol. 24, no. 1. Wayne, PA: NCCLS, 2004.
19. Johnson JR, Murray AC, Gajewski A, et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother 2003; 47:2161-8.
20. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181:261-72.
21. Johnson JR, Stell AL, Scheutz F, et al. Analysis of F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex polymerase chain reaction-based assay. Infect Immun 2000; 68:1587-99.
22. Picard B, Sevali Garcia J, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999; 67:546-53.
23. Johnson JR, Kuskowski M, Denamur E, Elion J, Picard B. Clonal origin, virulence factors, and virulence. Infect Immun 2000; 68:424-5.
24. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia versus uninfected control patients. J Infect Dis (in press).
25. Phillips I, Eykyn S, King A, et al. Epidemic multiresistant Escherichia coli infection in West Lambeth health district. Lancet 1988; 1:1038-41.
26. Duriez P, Clermont O, Bonacorsi S, et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 2001; 147:1671-6.
27. Barza M, Gorbach SL. The need to improve antimicrobial use in agriculture. Ecological and human health consequences. A report of the Facts about Antibiotics in Animals and the Impact on Resistance (FAAIR) project. Clin Infect Dis 2002;34(Suppl 3):S71-143.
28. Johnson JR, Kuskowski MA, Smith K, O'Bryan TT, Tatini S. Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods. J Infect Dis (in press).
29. Johnson JR, Stell A, Delavari P. Canine feces as a reservoir of extraintestinal pathogenic Escherichia coli. Infect Immun 2001; 69:1306-14.
30. Valvano MA, Silver RP, Crosa JH. Occurrence of chromosome- or plasmid-mediated aerobactin iron transport systems and hemolysin production among clonal group of human invasive strains of Escherichia coli K1. Infect Immun 1986; 52:192-9.
31. Johnson JR, Goullet PH, Picard B, Moseley SL, Roberts PL, Stamm WE. Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli causing urosepsis. Infect Immun 1991; 59:2311-5.
32. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 2001; 183:78-88.
33. Johnson JR, O'Bryan TT, Kuskowski MA, Maslow JN. Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia. Infect Immun 2001; 69:5363-74.
34. Welch R, Burland V, Plunkett GR, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2002; 99:17020-4.
35. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10:5274-6.